SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,515 | +21.0% | 3,733 | +14.3% | 0.01% | +40.0% |
| Q2 2023 | $373,907 | +71.5% | 3,265 | +155.7% | 0.01% | +25.0% |
| Q4 2020 | $218,000 | +3.8% | 1,277 | -14.2% | 0.00% | 0.0% |
| Q3 2020 | $210,000 | +556.2% | 1,489 | +365.3% | 0.00% | +300.0% |
| Q1 2020 | $32,000 | -23.8% | 320 | -2.1% | 0.00% | 0.0% |
| Q4 2019 | $42,000 | +68.0% | 327 | -0.6% | 0.00% | 0.0% |
| Q3 2019 | $25,000 | -50.0% | 329 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $50,000 | +19.0% | 328 | -7.9% | 0.00% | 0.0% |
| Q1 2019 | $42,000 | -17.6% | 356 | -23.6% | 0.00% | 0.0% |
| Q4 2018 | $51,000 | +1175.0% | 466 | +370.7% | 0.00% | – |
| Q3 2017 | $4,000 | – | 99 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |